Skip to content
lsd.com

Indication

Central Nervous System Agents

2 registered trials testing Psilocybin, Ketamine for this indication, 1 recruiting now.

2
Registered trials
1
Recruiting
1
In Phase 3

Substances tested

Being studied with

Stay told

When a new trial opens

Research alerts

Get a notification when a trial for Central Nervous System Agents trials starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

Trials

All 2 trials for Central Nervous System Agents

TrialStatusPhaseSubstanceSites
Nebulized Ketamine for the Treatment of Major Depressive DisorderNCT06752759 · Theresa Jacob, PhD, MPHRecruitingPhase 3ketamine1
Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term MeditatorsNCT01988311 · Johns Hopkins UniversityCompletedPhase 1psilocybin1

Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.